Stockscreener 앱 받기
0.4226
1.15%
-0.0049
시장 영업 전:
.42
-0.0026
-0.62%
전일 마감가:
$0.4275
열려 있는:
$0.43
하루 거래량:
223.85K
Relative Volume:
0.03
시가총액:
$2.92M
수익:
-
순이익/손실:
$-12.05M
주가수익비율:
-0.0672
EPS:
-6.2848
순현금흐름:
$-10.14M
1주 성능:
-9.16%
1개월 성능:
-26.56%
6개월 성능:
-69.60%
1년 성능:
-85.58%
1일 변동 폭
$0.41
$0.43
1주일 범위
$0.41
$0.4789
52주 변동 폭
$0.41
$3.16
Autonomix Medical Inc Stock (AMIX) Company Profile
명칭
Autonomix Medical Inc
전화
832-277-7816
주소
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
AMIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
0.4226 | 2.95M | 0 | -12.05M | -10.14M | -6.2848 |
|
ABT
Abbott Laboratories
|
108.27 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.61 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
354.57 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.69 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.60 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Autonomix Medical Inc 주식(AMIX)의 최신 뉴스
New RF ablation approach aims to ease pancreatic cancer pain - Stock Titan
Analysis Recap: Is Autonomix Medical Inc stock trending bullishWeekly Stock Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
Risk Recap: Is Autonomix Medical Inc a potential multi bagger2025 Investor Takeaways & Technical Pattern Based Signals - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) & Autonomix Medical (NASDAQ:AMIX) Financial Contrast - Defense World
Does Autonomix Medical Inc meet Warren Buffetts criteriaJuly 2025 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn
What analysts say about Autonomix Medical Inc. stock2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - bollywoodhelpline.com
Is Autonomix Medical Inc. stock cheap at current valuationJuly 2025 Reactions & Low Drawdown Momentum Ideas - bollywoodhelpline.com
Will Autonomix Medical Inc stock hit new highs in YEARJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - baoquankhu1.vn
Autonomix Medical receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Australia
Autonomix Medical receives Nasdaq notice for minimum bid price deficiency - Investing.com India
Autonomix Medical Receives Nasdaq Minimum Bid Price Notice - TipRanks
Autonomix Medical Received Notice of Noncompliance - TradingView
Gainers Report: Can Autonomix Medical Inc outperform under higher oil pricesEarnings Summary Report & Consistent Return Investment Signals - baoquankhu1.vn
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Increases By 1,052.8% - Defense World
Published on: 2026-01-13 18:33:29 - Bộ Nội Vụ
Autonomix Medical shares rally on positive pancreatic cancer pain data - MSN
Autonomix reports pain relief in pancreatic cancer patients across stages By Investing.com - Investing.com Nigeria
Why Autonomix Medical Inc. stock remains on buy listsMarket Risk Summary & Verified Trade Idea Suggestions - ulpravda.ru
Autonomix Medical stock soars after pain relief data in pancreatic cancer - Investing.com Australia
Autonomix (AMIX) Stock: Clinical Subgroup Analysis Supports Potential Palliative Impact of RF Denervation - parameter.io
Autonomix Medical Granted Patent for Cardiac Tissue Treatment - Medical Product Outsourcing
Autonomix Medical reports promising pain relief in pancreatic cancer - TipRanks
Autonomix reports pain relief in pancreatic cancer patients across stages - Investing.com
Autonomix Medical, Inc. Announces New Clinical Data on Pancreatic Cancer Pain Relief - TradingView — Track All Markets
Autonomix Medical stock soars after pain relief data in pancreatic cancer By Investing.com - Investing.com Canada
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - The Manila Times
Autonomix Medical Reports Positive Subgroup Analysis on Pain Relief in Pancreatic Cancer Patients Across All Disease Stages - Quiver Quantitative
Autonomix Medical announces pricing of $5M private placement - MSN
Can Autonomix Medical Inc. stock hit analyst price targets2025 Key Lessons & Proven Capital Preservation Tips - Улправда
How Autonomix Medical Inc. stock reacts to bond yieldsMarket Activity Summary & Weekly High Potential Stock Alerts - Улправда
Will Autonomix Medical Inc. stock outperform value stocks2025 Performance Recap & Expert Curated Trade Ideas - Улправда
Why Autonomix Medical Inc. stock remains resilientJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Улправда
Take Profit: Will Autonomix Medical Inc. stock attract ESG investorsMarket Trend Summary & Precise Swing Trade Alerts - Улправда
Growth Recap: How Autonomix Medical Inc stock reacts to bond yields2025 Volume Leaders & AI Powered Market Trend Analysis - moha.gov.vn
Was Autonomix Medical Inc (AMIX)’s session last reading good? - uspostnews.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Autonomix granted European patent on nerve-targeted therapies technology - MSN
Autonomix secures European patent for cardiac tissue treatment tech By Investing.com - Investing.com Nigeria
Silver Rises Sharply; Chicago PMI Surges In December - Benzinga
Autonomix Medical (AMIX) Stock: Skyrockets Following Major Patent Approval - parameter.io
Autonomix secures European patent for cardiac tissue treatment tech - Investing.com
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - The Manila Times
Autonomix Medical, Inc. Strengthens Global IP Portfolio with New European Patent for Advanced Cardiac Treatment Technologies - Quiver Quantitative
Autonomix Medical, Inc. Granted European Patent on Platform - GlobeNewswire
Autonomix Medical (NASDAQ:AMIX) Trading 1.7% Higher – Still a Buy? - Defense World
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - 富途牛牛
Autonomix Medical Inc (AMIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.36%
0.96%
자본화:
|
볼륨(24시간):